Seneca Biopharma, Inc.
(NASDAQ CM: SNCA)
Rigrodsky Law, P.A. is investigating Seneca Biopharma, Inc. (“Seneca”) regarding possible breaches of fiduciary duties and other violations of law related to Seneca’s agreement to merge with Leading BioSciences, Inc.